Our capstone project focuses on developing biomimetic 3D-bioprinted cartilage implants to improve treatment options for osteoarthritis patients. We design multilayer, macroporous scaffolds that mimic native cartilage architecture, combining β-TCP–doped and hydrogel layers to enhance osteointegration, mechanical performance, and tissue integration. These scaffolds are engineered to improve nutrient diffusion and support cell viability, enabling more durable cartilage repair. Ultimately, our goal is to create a minimally invasive, longer-lasting alternative that can delay or reduce the need for total joint replacement.